Together they address both vascular support and cellular migration phases of tissue repair
Completed research The clinical development program has generated substantial human data: Phase 1 safety studies in healthy volunteers Phase 2 trials in sarcoidosis with small fiber neuropathy Phase 2b trials evaluating corneal nerve regeneration Phase 2 trials in type 2 diabetes with neuropathy Multiple ophthalmic studies This represents significantly more human research than most peptides available to researchers
Monitoring, Labs, and Outcome Tracking Baseline labs typically include serum B12, methylmalonic acid (MMA), and homocysteine
Systemic Recovery & Gut-Brain Axis Support BPC-157 restores epithelial integrity in the gut, supporting the gut-brain axis and systemic immune regulation
2026 Europe PMC Buyer questions Common sourcing questions What makes BPC-157 different from a generic peptide listing
Order BPC-157 wholesale through a Canadian peptide supplier focused on dependable sourcing, inventory availability, and service